194 related articles for article (PubMed ID: 10646902)
1. Different types of FCgamma-receptors are involved in anti-Lewis Y antibody induced effector functions in vitro.
Dettke M; Loibner H
Br J Cancer; 2000 Jan; 82(2):441-5. PubMed ID: 10646902
[TBL] [Abstract][Full Text] [Related]
2. Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis.
Abrahams VM; Cambridge G; Lydyard PM; Edwards JC
Arthritis Rheum; 2000 Mar; 43(3):608-16. PubMed ID: 10728755
[TBL] [Abstract][Full Text] [Related]
3. Human monocyte-mediated cytotoxicity towards erythrocytes induced by hybrid mouse monoclonal antibodies: effect of antibody binding valency on IgG-Fc gamma R interaction.
Koolwijk P; Van de Winkel JG; Otten I; Bast BJ
Immunology; 1992 Feb; 75(2):336-42. PubMed ID: 1532380
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
[TBL] [Abstract][Full Text] [Related]
5. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
[TBL] [Abstract][Full Text] [Related]
6. CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.
van Ojik HH; Bevaart L; Dahle CE; Bakker A; Jansen MJ; van Vugt MJ; van de Winkel JG; Weiner GJ
Cancer Res; 2003 Sep; 63(17):5595-600. PubMed ID: 14500400
[TBL] [Abstract][Full Text] [Related]
7. FMLP- and TNF-stimulated monoclonal Lym-1 antibody-dependent lysis of B lymphoblastoid tumour targets by neutrophils.
Ottonello L; Morone P; Mancini M; Amelotti M; Dapino P; Dallegri F
Br J Cancer; 1999 May; 80(3-4):331-7. PubMed ID: 10408834
[TBL] [Abstract][Full Text] [Related]
8. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ
Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319
[TBL] [Abstract][Full Text] [Related]
9. Functional polymorphisms of Fc receptors in human monocyte-mediated cytotoxicity towards erythrocytes induced by murine isotype switch variants.
Boot JH; Geerts ME; Aarden LA
J Immunol; 1989 Feb; 142(4):1217-23. PubMed ID: 2492577
[TBL] [Abstract][Full Text] [Related]
10. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.
Akiyama Y; Lubeck MD; Steplewski Z; Koprowski H
Cancer Res; 1984 Nov; 44(11):5127-31. PubMed ID: 6435864
[TBL] [Abstract][Full Text] [Related]
11. FcgammaR cross-linking mediates NF-kappaB activation, reduced antigen presentation capacity, and decreased IL-12 production in monocytes without modulation of myeloid dendritic cell development.
Drechsler Y; Chavan S; Catalano D; Mandrekar P; Szabo G
J Leukoc Biol; 2002 Oct; 72(4):657-67. PubMed ID: 12377934
[TBL] [Abstract][Full Text] [Related]
12. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
[TBL] [Abstract][Full Text] [Related]
13. Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody.
Akewanlop C; Watanabe M; Singh B; Walker M; Kufe DW; Hayes DF
Cancer Res; 2001 May; 61(10):4061-5. PubMed ID: 11358826
[TBL] [Abstract][Full Text] [Related]
14. Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes.
Wiener E; Jolliffe VM; Scott HC; Kumpel BM; Thompson KM; Melamed MD; Hughes-Jones NC
Immunology; 1988 Oct; 65(2):159-63. PubMed ID: 3192267
[TBL] [Abstract][Full Text] [Related]
15. Mouse FcgammaRII is a negative regulator of FcgammaRIII in IgG immune complex-triggered inflammation but not in autoantibody-induced hemolysis.
Schiller C; Janssen-Graalfs I; Baumann U; Schwerter-Strumpf K; Izui S; Takai T; Schmidt RE; Gessner JE
Eur J Immunol; 2000 Feb; 30(2):481-90. PubMed ID: 10671203
[TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor alpha production by polymorphonuclear neutrophils treated with mouse anti-human CD19 monoclonal antibody.
Nishimura M
Cell Biochem Funct; 2004; 22(4):207-11. PubMed ID: 15248179
[TBL] [Abstract][Full Text] [Related]
17. Activation-dependent expression of the blood group-related lewis Y antigen on peripheral blood granulocytes.
Dettke M; Pálfi G; Loibner H
J Leukoc Biol; 2000 Oct; 68(4):511-4. PubMed ID: 11037972
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-colony stimulating factor enhances chimeric antibody Nd2 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils.
Tamamori Y; Sawada T; Nishihara T; Yamashita Y; Ohira M; Ho JJ; Kim YS; Hirakawa-Y S Chung K
Int J Oncol; 2002 Sep; 21(3):649-54. PubMed ID: 12168113
[TBL] [Abstract][Full Text] [Related]
19. Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.
Hristodorov D; Mladenov R; Brehm H; Fischer R; Barth S; Thepen T
MAbs; 2014; 6(5):1283-9. PubMed ID: 25517313
[TBL] [Abstract][Full Text] [Related]
20. Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells.
Brodzik R; Glogowska M; Bandurska K; Okulicz M; Deka D; Ko K; van der Linden J; Leusen JH; Pogrebnyak N; Golovkin M; Steplewski Z; Koprowski H
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8804-9. PubMed ID: 16720700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]